Key result
Coronary microembolization-induced heart failure in an ovine model significantly decreased mean arterial pressure (67 vs 85 mmHg, P<0.05) and altered baroreflex control of the heart.
Why the study?
Testing new therapies requires a chronic stable large-animal HF model, but neural control had not been previously explored in coronary microembolization models.
Absolute Event Rate: 67% vs 85%
p-value: p=<0.05
The ovine multiple coronary microembolization model successfully replicates the impaired baroreflex function and hemodynamic changes seen in human heart failure, providing a stable large animal model for testing new therapies.
Ovine microembolization model aids preclinical HF research; leaves open translation of baroreflex changes to patients.
Testing new therapies in heart failure (HF) requires a chronic stable model of HF in large animals. Microembolization of the coronary arteries has been used to model HF previously, however, neural control has not been previously explored in this model. Thus the aim of this study was to further characterize neural control in this model of HF. HF was induced by infusion of microspheres (45 micron; 1.3 mL) into the proximal left coronary artery or left descending coronary arteries, with three sequential embolizations over 3 weeks. Twelve to 14 weeks after the final embolization, and when ejection fraction had decreased below 45%, animals were instrumented to record blood pressure and heart rate. Baroreflex control of heart rate was investigated in conscious animals. Additionally, pressure-volume loops were constructed under anaesthesia. Embolization-induced HF was associated with a decrease in mean arterial pressure (67 ± 2 vs 85 ± 4 mmHg, P4s, P<0.05), compared to control sheep. The microembolization model of heart failure is associated with an increase in left ventricular end-diastolic pressure, impaired cardiac function and altered baroreflex control of the heart. These findings suggest this chronic model of HF is appropriate to use for investigating interventions aimed at improving neural control in HF.
No takes yet. Share an insight, caveat, or question.
Abukar et al. (2019) studied Chronic Heart Failure. Coronary microembolization vs. Control sheep was evaluated on Mean arterial pressure (mmHg) (p=<0.05). Coronary microembolization-induced heart failure in an ovine model significantly decreased mean arterial pressure (67 vs 85 mmHg, P<0.05) and altered baroreflex control of the heart.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: